Zobrazeno 1 - 10
of 195
pro vyhledávání: '"D. Urbanitz"'
Autor:
H P Lohrmann, Bodenstein H, C. Käufer, U. Ohl, H Hill, L Balleisen, Fischer Jt, D. Urbanitz, H. Rauschecker, Hansjochen Wilke, J. C. Preiss, C.H. Köhne, Carsten Bokemeyer, Wolfgang Hiddemann, H.-J. Schmoll
Publikováno v:
Oncology. 54:96-101
Biochemical modulation of 5-fluorouracil (5-FU) by folinic acid (FA) increases the response rate in patients with metastatic colorectal cancer compared to 5-FU alone. Phase II trials also demonstrated increased efficacy when interferon was added to 5
Autor:
V. Diehl, M. Loeffler, M. Pfreundschuh, U. Ruehl, D. Hasenclever, H. Nisters-Backes, M. Sieber, K. Smith, H. Tesch, W. Geilen, M. Adler, H. Bartels, U. Brandenburg, P. Diezler, G. Doelken, J. Enzian, R. Fuchs, W. Gassmann, H. Gerhartz, U. Hagenaukamp, T. Hecht, E. Hiller, H. Hinkelbein, B. Lathan, H. Kirchner, G. Kuehn, H. Kuerten, U. Loos, B. Makoski, W. Oertel, S. Petsch, R. Pfab, H. Pflueger, M. Planker, R. Rohioff, H. Sack, S. Samandari, R. Sauer, K. Schalk, G. Schmitz, W. Schoppe, G. Schwieder, S. Szepesi, J. Teichmann, W. Wilhelmy, P. Worst, R. Fischer, A. Georgii, K. Huebner, E.W. Schwarze, R. Rohloff, U. Hagen-Aukamp, H. Kürten, M. Westerhausen, H. Pflüger, J. Entzian, G. Dölken, H. Ernst, J. König, H. Hellriegel, G. Kühn, U. Rühl, null Szepesi, U. Schulz, S. Theml, R. Staiger, W. Haase, T. Wagner, null Brandenburg, I. Boldt, H.J. Schmoll, H. Emminger, W. Gaβmann, T. Brix, B. Mödder, H. Hennekeuser, G. Schlimok, null Doukas, A.-C. Voss, B. Krüger, K. Kutzner, F. Hinrichs, A. Temmesfeld, T. Luska, H.D. Schick, J. Preiβ, W. Gärtner, W. Mende, W. Alberti, U. Hoffmann, D. Urbanitz, null Heide, H. Siebner, K.H. van de Weyer, D. Dornoff, E. Renner, M. Cohen, P. Czygan, H.W. Scheja, J. Schoenemann, M. Rochell, U. Peters, K. Koniczek, D. Mitrenga, U. Cammerer, W. Mantel, K. Hübner, Volker Diehl
Publikováno v:
Annals of Oncology. 6:901-910
Summary Objective It was the aim of this prospective randomized multicenter study to compare chemotherapy and radiotherapy as consolidation treatments in patients achieving complete remission (CR) after 6 cycles of doxorubicin-containing chemotherapy
Autor:
R. Leo, B. R. Suchy, J. Oertel, J. Währisch, Helmuth Deicher, M. Planker, C.-H.-R. Hauswaldt, K. Görg, A. Georgii, C. Tirier, H. Gamm, J. Karow, K. Schumacher, M. Sailer, H.J. Keyserlingk, R. Coldewey, M. Gramatzki, D. Peest, Volker Diehl, H. M. Reinold, A. Kindler, V. Hiemeyer, U. Essers, E. Schäfer, C. Vykoupil, E. Hoeppner, S. Glück, D. Urbanitz, E. Heilmann
Publikováno v:
European Journal of Cancer. 29:978-983
Follow-up data of 320 multiple myeloma (MM) patients entering the German Myeloma Treatment Group (GMTG) trial MM01 were analysed for factors predicting overall (OAS) and tumour related survival (TRS). Response to primary induction chemotherapy was re
Autor:
W, Hiddemann, H C, Aul, G, Maschmeyer, D, Urbanitz, B, Lathan, A, Reichle, H, Köppler, R, Donhuijsen-Ant, W D, Ludwig, T, Grüneisen
Publikováno v:
Haematology and blood transfusion. 33
Autor:
Th. Büchner, A. Reichle, Achim Heinecke, W. Schroyens, Georg Maschmeyer, P. Bettelheim, D. Urbanitz, Wolfgang Hiddemann, R. Donhuijsen-Ant, Hubert Köppler, W.-D. Ludwig, Leopold Balleisen, T. Grüneisen, B. Lathan, H. Bartels, C. Sauerland, H. C. Aul
Publikováno v:
Acute Leukemias II ISBN: 9783540509844
In spite of the substantial improvement of first-line treatment in adult patients with acute myeloid leukemia (AML) and a grad-ual increase in long-term remissions, the majority of patients still relapse with their disease and ultimately die due to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d4ee52ea8f95cfa6ddbe066b63c70b3
https://doi.org/10.1007/978-3-642-74643-7_110
https://doi.org/10.1007/978-3-642-74643-7_110
Adult AML: The Role of Chemotherapy Intensity and Duration. Two Studies of the AML Cooperative Group
Autor:
A. Heyll, K.-H. Zurborn, D. Hossfeld, A. Heinecke, Ch. Anders, W. Siegert, K. Mainzer, C. Tirier, W.D. Ludwig, R. Emmerich, H.H. Fülle, L. Balleisen, J. Karow, Th. Büchner, R. Mertelsmann, C. Aul, R. Kuse, K.-P. Hellriegel, D. Urbanitz, M. Baldus, E. Thiel, H. Löffler, H.J. König, M. Planker, W. Gassmann, R. Fuchs, H. Sodomann, H. Seibt-Jung, E. König, W. Hiddemann, L. Leimer, K. H. Heitzelmann, B. Lathan, P. Koch, H. Köppler, M. C. Sauerland, W. Augener, U. Schmitz-Huebner, M.R. Nowrousian, M. Schroeder, H. Bartels, L. Nowicki, K. Straif, G. Maschmeyer, E. Lengfelder, I. Meuthen, R. Donhuijsen-Ant, J. Schwammborn, H.A. Vaupel, G. Middelhoff, S. Blasius, R. Michels-Giermann, A. Ho, H. G. Fuhr, H. Eimermacher, K. Becker
Publikováno v:
Acute Leukemias II ISBN: 9783540509844
Further improvement of chemotherapy for acute myeloid leukemia (AML) requires an evaluation of alternative treatment strategies as investigated in adequate prospective multicenter trials. Since no superior new drugs are available, treatment can be im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01b4118d282c59f48cf9fbed3bb43c2c
https://doi.org/10.1007/978-3-642-74643-7_47
https://doi.org/10.1007/978-3-642-74643-7_47
Publikováno v:
Klinische Wochenschrift. 64:1029-1035
Lysostaphin, a staphylococcus-derived staphylocidal substance, has widely been used in assays of granulocyte phagocytic and bactericidal capability. It rapidly kills extracellular bacteria. Thus, a separate determination of intracellular surviving ba